Clinical Trials Browser

Phase 3 × Leukemia, Myeloid, Acute × Dasatinib × Clear all

NCT02013648 2024-02-23

Randomized Phase III Study of Intensive Chemotherapy With or Without Dasatinib (Sprycel™)

Phase 3 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute